Interactions of Impaired Glucose Transport and Phosphorylation in Skeletal Muscle Insulin Resistance: A Dose-Response Assessment Using Positron Emission Tomography

Diabetes

Volumn 50, Issue 9, 2001, Pages 2069-2079

  Williams, Katherine V ^a   Price, Julie C ^a   Kelley, David E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY WEIGHT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RADIOGRAPHY; SCINTISCANNING; SKELETAL MUSCLE; THIGH; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; THIGH; THINNESS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035462585     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.9.2069     Document Type: Article

References (31)

1. Saccomani MP, Bonadonna RC, Bier DM, DeFronzo RA, Cobelli C: A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. Am J Physiol 270:E170-E185, 1996
2. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1990
3. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1069-1075, 1992
4. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl. Acad Sci U S A 92:983-987, 1995
5. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240-246, 1999
6. Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Theriault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705-2713, 1996
7. Kelley DE, Williams KV, Price JC: Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by positron emission tomography. Am J Physiol 40:E361-E369, 1999
8. Sheperd PR, Kahn BB: Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248-257, 1999
9. Wilson JE: Hexokinases. Rev Physiol Biochem Pharmacol 126:65-198, 1995
10. Kelley DE, Williams KV, Price JC, Goodpaster BH: Determination of the lumped constant for [18F]FDG in human skeletal muscle. J Nucl Med 40:1798-1804, 1999
11. 18F]-fluoro-deoxy-glucose in human skeletal muscle, measured simultaneously with PET and microdialysis (Abstract). Diabetes 48 (Suppl. 1):A296, 1999
12. Hamacher K, Coenen HH, Stocklin G: Efficient stereospecific synthesis of no-carrier-added 2-[18]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238, 1986
13. Barnes D, Egan G, O'Keefe G, Abbott D: Characterization of dynamic 3-D PET imaging for functional brain mapping. IEEE Trans Med Imaging 16:261-269, 1997
14. Bailey DL, Young H, Bloomfield PM, Meilke SR, Glass D, Myers MJ, Spinks TJ, Watson CC, Luk P, Peters M, Jones T: ECAT ART: a continuously rotating PET camera, performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department. Eur J Nucl Med 24:6-15, 1997
15. Watson CC, Newport D, Casey ME: A single scatter simulation technique for scatter correction in 3-D PET. Proceedings of the 1995 International Meeting on Fully Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine, 1995, p. 215-219
16. Ollinger JM: Model-based scatter correction for fully 3-D PET. Phys Med Biol 41:153-176, 1996
17. Colberg SR, Simoneau JA, Thaete FL, Kelley DE: Skeletal muscle utilization of free fatty acids in women with visceral obesity. J clin Invest 95:1846-1853, 1993
18. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916, 1977
19. Huang S, Phelps ME: Principles of tracer kinetic modeling in positron emission tomography and autoradiograpy. In Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. Phelps ME, Mazziotta JC, Schelbert HR, Eds. New York, Raven Press, 1986, p. 287-346
20. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE: Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238:E69-E82, 1980
21. 18F]fluorodeoxyglucose/PET data. J Nucl Med 30:1483-1488, 1989
22. Furler SM, Jenkins AB, Storlien LH, Kraegen EW: In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. Am J Physiol 261 (3 Pt 1):E337-E347, 1991
23. Zierler K: Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady states. J Clin Invest 40:2111-2125, 1961
24. Kolterman OG., Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
25. Reinhardt M, Markus B, Vosberg H, Herzog H, Hubinger A, Reinauer H, Muller-Gartner H: Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET. J Nucl Med 40:977-985, 1999
26. Carson ER, Jones EA: Use of kinetic analysis and mathematical modeling in the study of metabolic pathways in vivo. N Engl J Med 300:1016-1027, 1979
27. Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Pendergrass M, Koval J, Ardehali H, Printz R, Granner D, DeFronzo R, Mandarino L: Effects of insulin on subcellular localization of hexokinase II in human skeletal muscle in vivo. J Clin Endocrinol Metab 83:230-234, 1998
28. Huang SC, Williams BA, Barrio JR, Krivokapich J, Nissenson C, Hoffman EJ, Phelps MK: Measurement of glucose and 2-deoxy-2-[18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dualtracer kinetic experiments. FEBS Lett 216:128-132, 1987
29. Crane PD, Pardridge WM, Braun LD, Oldendorf WH: Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain. J Neurochem 40:160-167, 1983
30. Doenst T, Han Q, Goodwin GW, Guthrie PH, Taegtmeyer H: Insulin does not change the intracellular distribution of hexokinase in rat heart. Am J Physiol 275:E558-E567, 1998
31. Utriainen T, Lovisatti S, Makimattila S, Bertoldo A, Weintraub S, DeFronzo R, Cobelli C, Yki-Jarvinen H: Direct measurement of the lumped constant for 2-deoxy-[1-(14)C]glucose in vivo in human skeletal muscle. Am J Physiol Endocrinol Metab 279:E228-E233, 2000